Shares of Medtronic Plc (NYSE: MDT) declined this week, despite the company reporting stronger-than-expected Q3 2026 earnings. Investors were unsettled…
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) reported fourth-quarter 2025 results showing continued commercial uptake of its lead product Rezdiffra (resmetirom), with…